Van Keimpema, Loes

Publishing since 2008 (Baby)

Has published 7 publications in 3 years

Number of publications published per year by Van Keimpema, Loes. (Source : PubMed)

Distribution of publications types for Van Keimpema, Loes. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Waanders E, van Keimpema L, Drenth JP. Comment on: How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects?  Dig Liver Dis  2010;42;3  
•  van Keimpema L, Nevens F, Vanslembrouck R, van Oijen MG, Hoffmann AL, Dekker HM, de Man RA, Drenth JP. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.  Gastroenterology  2009;137;5  
•  Waanders E, van Keimpema L, Brouwer JT, van Oijen MG, Aerts R, Sweep FC, Nevens F, Drenth JP. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease.  Liver Int.  2009;29;9  
•  van Keimpema L, Drenth JP. Effect of octreotide on polycystic liver volume.  Liver Int.  2009  
•  van Keimpema L, de Man RA, Drenth JP. Somatostatin analogues reduce liver volume in polycystic liver disease.  Gut  2008;57;9  
•  van Keimpema L, de Koning DB, Strijk SP, Drenth JP. Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts.  Dig. Dis. Sci.  2008;53;8  
•  van Keimpema L, Ruurda JP, Ernst MF, van Geffen HJ, Drenth JP. Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%.  J. Gastrointest. Surg.  2008;12;3  

[ See timeline ] [ See all publications ]